CHRISTIE POOLE: Open Payments
NPI 1093208241 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,598 in 85 payments from 28 companies in 2025. Trend: 2023 $1,267 · 2024 $4,491 · 2025 $1,598
Food & beverage: $1,598
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 16 | $235 |
| Tandem Diabetes Care, Inc. | 9 | $148 |
| Lilly USA, LLC | 5 | $103 |
| Amgen Inc. | 6 | $92 |
| Madrigal Pharmaceuticals | 3 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Radius Health, Inc. | 3 | $68 |
| BETA BIONICS, INC. | 5 | $62 |
| CeQur Corporation | 1 | $61 |
| Amneal Pharmaceuticals LLC | 3 | $60 |
Products named: Omnipod, t:slim X2 Insulin Pump with Control-IQ, REZDIFFRA, JARDIANCE, REPATHA, LEQVIO, Tymlos, iLet Bionic Pancreas.
Industry payments across TX — which companies pay providers there.
